WB result of BNIP3 Recombinant Rabbit mAb
Primary antibody: BNIP3 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HeLa whole cell lysate 20 µg
Lane 2: HeLa treated with 100 μM cobalt chloride overnight whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 22 kDa
Observed MW: 30 kDa
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | BNIP3 |
| Synonyms | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3; NIP3 |
| Immunogen | Synthetic Peptide |
| Location | Mitochondrion |
| Accession | Q12983 |
| Clone Number | S-2979-65 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB |
| Reactivity | Hu, Rt |
| Positive Sample | HeLa (treated with 100 μM cobalt chloride overnight), SH-SY5Y, rat kidney |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| WB | 1:1000 | Hu, Rt |
Background
BNIP3 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3) is a pro-apoptotic member of the BH3-only subgroup within the BCL-2 protein family that plays a pivotal role in regulating mitochondrial dynamics, cell death, and autophagy, particularly under hypoxic conditions. Structurally characterized by a transmembrane domain at its C-terminus which anchors it to the outer mitochondrial membrane, BNIP3 functions as a direct transcriptional target of Hypoxia-Inducible Factor 1-alpha (HIF-1α), allowing cells to respond to low oxygen levels by disrupting the interaction between anti-apoptotic proteins like BCL-2 and pro-survival factors, thereby inducing mitochondrial depolarization, reactive oxygen species (ROS) generation, and either apoptosis or protective mitophagy depending on the cellular context and stress intensity. Beyond its canonical role in hypoxia-induced cell death, BNIP3 is critically involved in metabolic reprogramming, cardiac physiology, and cancer progression, where its dual capacity to trigger cell elimination or promote survival through the clearance of damaged mitochondria makes it a complex and context-dependent regulator of cellular homeostasis and a potential therapeutic target in diseases ranging from myocardial ischemia to various malignancies.
Picture
Picture
Western Blot
WB result of BNIP3 Recombinant Rabbit mAb
Primary antibody: BNIP3 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: SH-SY5Y whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 22 kDa
Observed MW: 30 kDa
WB result of BNIP3 Recombinant Rabbit mAb
Primary antibody: BNIP3 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: rat kidney lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 22 kDa
Observed MW: 40 kDa
